Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pharmacists may help curb deadly Opioid-Alcohol mix

NCT ID NCT05599672

Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a brief counseling program delivered by pharmacists to help people who take prescription opioids and also drink alcohol. The program combined medication review with motivational interviewing to encourage safer use. Researchers enrolled 112 adults and measured changes in alcohol and opioid use. The goal was to see if the approach is acceptable and practical for a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Alcohol-targeted Brief Intervention-Medication Therapy Management (ABI-MTM)
What this could lead to
If successful, this program could provide a practical way for pharmacists to help people reduce dangerous mixing of opioids and alcohol.
What could go wrong
This is a small, early-stage study testing feasibility and preliminary effects, not a proven treatment. Results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

112 people

The number who actually took part.

Started

May 2023

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * English speaking * ≥18 years * Not receiving cancer treatment * Current alcohol use * Prescribed an opioid medication Exclusion Criteria: * SA 2 exclusion * Are pregnant * Cannot provide collateral contact information for ≥2 persons * Do not have a reliable land line or mobile phone to be contacted by study staff * Are filling only buprenorphine * Plan to leave the area for an extended period of time in the next 3-months, or * Have experienced a psychotic and/or manic episode in the last 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol drinking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alcohol Drinking opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol drinking Opioid use

Contacts and locations

Locations

  • University of Tennessee College of Medicine

    Nashville, Tennessee, 38103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.